(4E)-1-(5-benzylsulfanyl-1,3,4-thiadiazol-2-yl)-5-(3-bromophenyl)-4-[hydroxy(pyridin-4-yl)methylidene]pyrrolidine-2,3-dione
Formula:C25H17N4O3BrS2
Mutagenic:none
Tumorigenic:none
Reproductive Effective:low
(4E)-1-(5-benzylsulfanyl-1,3,4-thiadiazol-2-yl)-5-(3-bromophenyl)-4-[hydroxy(pyridin-4-yl)methylidene]pyrrolidine-2,3-dione is not a drug-like molecule.
| MolName | (4E)-1-(5-benzylsulfanyl-1,3,4-thiadiazol-2-yl)-5-(3-bromophenyl)-4-[hydroxy(pyridin-4-yl)methylidene]pyrrolidine-2,3-dione |
| MolecularFormula | C25H17N4O3BrS2 |
| Smiles | O/C(/c1ccncc1)=C(\C(c1cccc(Br)c1)N(C1=O)c2nnc(SCc3ccccc3)s2)/C1=O |
| InChI | InChI=1S/C25H17BrN4O3S2/c26-18-8-4-7-17(13-18)20-19(21(31)16-9-11-27-12-10-16)22(32)23(33)30(20)24-28-29-25(35-24)34-14-15-5-2-1-3-6-15/h1-13,20,31H,14H2/t20-/m1/s1 |
| InChIK | LDQKXJSDQXWVLP-HXUWFJFHSA-N |
| TotalMolweight | 565.471 |
| Molweight | 565.471 |
| MonoisotopicMass | 563.992542 |
| CLogP | 4.4577 |
| CLogS | -6.24 |
| H Acceptors | 7 |
| H Donors | 1 |
| TotalSurfaceArea | 368.71 |
| Relative PSA | 0.3078 |
| PolarSurfaceArea | 149.82 |
| Druglikeness | -0.53333 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | low |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.48571 |
| Fragments | 1 |
| Non HAtoms | 35 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| StereoCenters | 1 |
| Rotatable Bond | 6 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 23 |
| Sp3Atoms | 4 |
| Symmetricatoms | 4 |
| Amides | 1 |
| Aromatic Nitrogens | 3 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (4E)-1-(5-benzylsulfanyl-1,3,4-thiadiazol-2-yl)-5-(3-bromophenyl)-4-[hydroxy(pyridin-4-yl)methylidene]pyrrolidine-2,3-dione | 2 - (4E)-1-(5-benzylsulfanyl-1,3,4-thiadiazol-2-yl)-5-(3-bromophenyl)-4-[hydroxy(pyridin-4-yl)methylidene]pyrrolidine-2,3-dione
Spacefill |
Wire |
Ball & Stick |
Iso-vdw |
Opaque |
Dot Surface |
Mep |
Translucent |
Spin |
Label On |
Off